APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds | News | APMA
APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds

APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds Members Only Content

APMA recommended deleting the language in the NCD stating autologous PRP is non-covered when used for the treatment of “chronic, non-healing, cutaneous wounds.”

This content is available to APMA members only. If you are a member, please log in to see the full content.



Related Resources

CMS Instructs MACs to Hold Claims as of April 1 - Pending Extension of Sequester Suspension

Learn More

PPP Extended—Apply by May 31

Learn More

ADVERTISEMENT
Check out the APMA Buyers Guide for all your podiatric office needs!